Skip to main content
Cancer Explained
Donate
Beginner 5 min readSource checked

What Do LI-RADS 3, 4, and 5 Mean?

LR-3, LR-4, and LR-5 are three rungs on the LI-RADS probability ladder, and each one leads to a different next step.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

Source

American College of Radiology — LI-RADS

A woman in headscarf stands in a clinic hallway near an MRI machine
A woman in headscarf stands in a clinic hallway near an MRI machine

Key fact

LI-RADS is only applied to people already at high risk of liver cancer, such as those with cirrhosis or chronic hepatitis B.

The short answer

In CT/MRI LI-RADS v2018, LR-3 means intermediate probability of malignancy, LR-4 means probably HCC, and LR-5 means definitely HCC. The system only applies to livers already known to be at high risk.

  • LI-RADS is only applied to people already at high risk of liver cancer, such as those with cirrhosis or chronic hepatitis B.

  • LR-5 is the one category that can stand in for a biopsy, because it is defined to match the criteria the AASLD uses.

  • The number comes from lesion size plus a short list of contrast features, not from a radiologist's overall impression.

Choose how you want to understand this

The full explanation.

The system only applies to some livers

Before the number means anything, the patient has to fit. The CT/MRI LI-RADS v2018 core says to apply it in people at high risk for hepatocellular carcinoma, namely those with:

  • cirrhosis, or
  • chronic hepatitis B infection, or
  • current or prior HCC, including adult liver transplant candidates and recipients.

The same page says not to apply it to people without those risk factors, or to anyone under 18. It is also ruled out when cirrhosis comes from congenital hepatic fibrosis, or from a vascular disorder such as Budd-Chiari syndrome or cardiac congestion.

A spot on a healthy liver is not an LR-anything. If a report uses LI-RADS wording anyway, it is worth asking why.

What the three words actually say

LI-RADS calls each finding an observation. The v2018 wording for the middle rungs is short:

  • LR-3 — intermediate probability of malignancy.
  • LR-4 — probably HCC.
  • LR-5 — definitely HCC.

The manual describes the mix behind each one. LR-3 observations vary from benign, through dysplastic nodules, to HCC. Most but not all LR-4s are HCC. Almost all LR-5s are HCC.

It also states plainly that the categories reflect probabilities and do not correspond to exact histological categories.

Size and four features set the number

The number is not a general impression. It comes from a table.

The radiologist first checks for nonrim arterial phase hyperenhancement. That means the spot lights up early with contrast, in a set pattern. Then they measure it. There are three size bands: under 10 mm, 10 to 19 mm, and 20 mm or more.

Then they count how many of three extra major features are present:

  • an enhancing "capsule" around the edge
  • nonperipheral "washout", where the observation fades faster than the liver around it
  • threshold growth, defined in v2018 as a size increase of at least 50% within 6 months or less

More features and more millimeters push the number up. An early-enhancing observation of 20 mm or more with no extra feature is LR-4. The same observation at 10 to 19 mm with washout is LR-5.

If the radiologist is unsure whether a feature is there, the rule is to treat it as absent.

Why LR-5 can replace a biopsy

LR-5 is the odd one out. In v2018 its criteria were rewritten to match those used by the American Association for the Study of Liver Diseases.

That is why the management table beside it reads "HCC confirmed" rather than "get tissue". In an at-risk liver, imaging that meets these criteria is accepted as the diagnosis.

The reverse is not true. The manual notes three kinds of HCC that cannot be called LR-5: those under 10 mm, those without arterial enhancement, and those with odd features such as rim enhancement. A liver cancer can exist and still not earn the label.

What each rung leads to

The v2018 core prints management suggestions agreed jointly by the AASLD and LI-RADS:

  • LR-3 — repeat or alternative diagnostic imaging in 3 to 6 months.
  • LR-4 — multidisciplinary discussion for a tailored workup, which may include biopsy.
  • LR-5 — HCC confirmed, then multidisciplinary discussion for agreed management.

Notice that only one of these is a treatment decision. The other two buy information.

An LR-3 can go either way

LR-3 is the rung that unsettles people most, because it commits to nothing.

Many LR-3s turn out to be vascular pseudolesions, which are quirks of blood flow rather than growths. Others are dysplastic nodules. Some are early cancer.

LI-RADS also allows ancillary features to nudge a category up by one, as far as LR-4. They are not allowed to push anything up to LR-5. That ceiling is deliberate: the strongest label needs the strongest evidence.

What to ask about a LI-RADS report

  • Which category, and how large was the observation?
  • Which major features were seen, and which were called absent?
  • Was this compared with an older scan?
  • Does my liver history match the at-risk group LI-RADS assumes?
  • Who is reviewing this, and when does the liver team meet?

When to get help sooner

A LI-RADS category is about images, not about how you feel today. Do not wait for the next scan if any of the following happens.

  • Call 911 or go to an emergency department if you vomit blood, or pass black tarry stools. In a liver at risk, this can mean bleeding from enlarged veins in the food pipe or stomach, which NIDDK lists as a serious complication of cirrhosis.
  • Call 911 or go to an emergency department if you become confused, very drowsy, or hard to wake. Confusion, trouble thinking, and personality change are recognised effects of a failing liver.
  • Call your care team the same day if the whites of your eyes or your skin turn yellow, or your belly swells quickly and becomes painful. Jaundice and fluid buildup in the belly are both listed among liver cancer symptoms.
  • Call your care team within a day or two if you bruise or bleed more easily than usual, or you have a fever with no clear cause.

The system as a whole is covered in What Does LI-RADS Mean. See also Liver Lesion on CT: What Now, Liver Cancer, and Imaging Tests.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

A woman in headscarf and younger woman embrace warmly near a laptop

Common questions

Does LR-5 mean I definitely have liver cancer?

LR-5 means the imaging meets the criteria for definite HCC in an at-risk liver, and the v2018 management table treats it as HCC confirmed. The manual is careful to say the categories reflect probability, not exact histology.

Why did my LR-3 not get a biopsy?

The v2018 management table pairs LR-3 with repeat or alternative diagnostic imaging in 3 to 6 months. LR-3 lesions range from harmless to cancer, and time often sorts them out.

Can LI-RADS be used on any liver spot?

No. The v2018 core says not to apply it to people without the listed risk factors, to anyone under 18, or to cirrhosis caused by congenital hepatic fibrosis or a vascular disorder.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from American College of Radiology — LI-RADS material and checked line by line against the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-11 what this meansLast updated: 2026-08-11Next planned review: 2027-07-21

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 9 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What Do LI-RADS 3, 4, and 5 Mean?